Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Lehmann-Che
Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
PLoS ONE
Multidisciplinary
Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers
Breast Cancer Research and Treatment
Cancer Research
Oncology
Novel Immunohistochemistry-Based Signatures to Predict Metastatic Site of Triple-Negative Breast Cancers
British Journal of Cancer
Cancer Research
Oncology
The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice
Cancer Prevention Research
Medicine
Cancer Research
Oncology
A Robust Classifier of High Predictive Value to Identify Good Prognosis Patients in ER-negative Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Estrogen Receptor (ER ) Level but Not Its ER Cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Gene Signature of Loss of Oestrogen Receptor (ER) Function and Oxidative Stress Links ER-positive Breast Tumours With an Absent Progesterone Receptor and a Poor Prognosis
Breast Cancer Research
Cancer Research
Oncology
Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer
Frontiers in Genetics
Genetics
Molecular Medicine
The Integrin v 3-5 Ligand MFG-E8 Is a P63/P73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers
Cancer Research
Cancer Research
Oncology
